S&P 500
5,985.96
+0.3%
+$15.59
DJI
42,578.31
+0.1%
+$58.67
NASDAQ
19,478.50
+0.4%
+$79.54
Bitcoin
105,345.00
-0.7%
-700.28
AAPL
$203.25
-0.0%
-$0.02
AMZN
$207.66
+0.9%
+$1.95
GOOG
$169.03
+0.8%
+$1.32
META
$684.25
+2.6%
+$17.40
MSFT
$464.75
+0.4%
+$1.78
NVDA
$141.14
-0.1%
-$0.08
TSLA
$334.14
-2.9%
-$10.13
Urologix (OTC: ULGX)
$0.00
(0.0%)
$0.00
Price as of May 27, 2025, 12:40 p.m. ET
Urologix Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Urologix Company Info
Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia. The company was founded by Mitchell Dann and John M. Reid on May 29, 1991 and is headquartered in Minneapolis, MN.
News & Analysis
No articles found.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.